Media advisory - Governor General to present Meritorious Service Decorations (Civil Division) to exceptional individuals
OTTAWA, ON, March 19, 2024 /CNW/ - Her Excellency the Right Honourable Mary Simon, Governor General of Canada, will present a total of 64 Meritorious Service Decorations (Civil Division), including 8 Meritorious Service Crosses (M.S.C.) and 56 Meritorious Service Medals (M.S.M.), during a ceremony at Rideau Hall on Thursday, March 21.
To guarantee your access to the ceremony, we ask that you please confirm your attendance with the Rideau Hall Press Office at [email protected]
Media are asked to arrive at the Princess Anne Entrance no later than 10:30 a.m. on the day of the ceremony.
Official photos will be made available upon request.
About the Meritorious Service Decorations (Civil Division)
The Meritorious Service Decorations (Civil Division) were created by Queen Elizabeth II to recognize great Canadians for an exceptional deed they accomplished over a limited period of time that brings honour to our country. They honour activities or deeds that are often innovative, set an example or model for others to follow, or improve the quality of life in a community.
There are two levels: a cross and a medal. The different levels reflect the scope and impact of the activity or deed. The Meritorious Service Decorations (Civil Division) are part of the Canadian Honours System and are one of the highest honours a Canadian civilian can receive.
Tri-Tech Forensics, Inc. (Tri-Tech), a leading provider of tactical emergency medical solutions and human identification kits, is pleased to announce the acquisition of SAM® Medical (SAM Medical), a globally renowned provider of innovative medical...
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2
The...
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...
NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the...